Gorbach-Goldin

Gorbach-Goldin is a biotechnology entity primarily known for the discovery and commercialization of the Lactobacillus rhamnosus GG (LGG) probiotic strain. Founded by Dr. Sherwood Gorbach and Dr. Barry Goldin, the company focused on the therapeutic potential of specific microbial strains to treat gastrointestinal and immunological conditions. Their work led to the development of one of the most widely researched and commercially successful probiotic strains in the world, which has been licensed to various global food and pharmaceutical companies. The company's legacy is centered on the clinical validation of live biotherapeutic products for human health.